COVID-19 Vaccine Education and Equity Project

PROJECT PRINCIPLES

Vaccines must continue to adhere to a gold-standard review process.
Approval and dissemination of COVID-19 vaccines should be based on:

  • Robust clinical trials that include diverse patient populations
  • Public disclosure of results from Phase 3 clinical trials, in accordance with FDA guidance
  • Authorization and subsequent approval based on evidence generated from clinical trials and well-established review processes at FDA
  • Transparent and ongoing post-marketing safety surveillance

Core Objectives

Open dialogue, engagement and effective communication is important to address the skepticism around vaccines that exists among many people and in many communities. Additionally, building confidence in the process and the science is key for authorized and approved vaccines to be a contributor to addressing health inequities that exist generally and specifically with respect to COVID-19. To achieve its mission, the COVID-19 Vaccine Education and Equity Project seeks to:

Provide education on, and advocate for, adherence to a gold-standard regulatory review process

Raise awareness around the importance of COVID-19 vaccination for public health, the economy and broader society

Promote the impact of widespread COVID-19 vaccination uptake in protecting individuals, families, and communities

Lead a conversation that helps ensure equitable access to authorized and approved vaccines through equitable access to information and dialogue

Members

Convening Organizations

The COVID-19 Vaccine Education and Equity Project is led by the Alliance for Aging Research, Healthy Women, and the National Caucus and Center on Black Aging.


Partners

Join The Project

Join our efforts to build trust and confidence in authorized and approved COVID-19 vaccines.

Please upload image that is at least 250px width and 100px height